Sep 13, 2020 8:00 AM EDT. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few … AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Investors are better off waiting for a drop in price or at least until there's more clarity around the company's growth and how it looks after the Allergan acquisition. Market data powered by FactSet and Web Financial Group. Second, AbbVie's dividend yield of 5.3% enables investors to enjoy a pretty good total return even if the stock doesn't rise very much. Despite the added overhead, Allergan's top line grew by just 3.6%. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. AbbVie stock opened at $107.15 on Friday. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. AbbVie Inc stock is rated a Sell. Disclaimer | Macroaxis provides AbbVie buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. I think AbbVie is a slam-dunk buy right now. But we must note that the investments were made at well below today's share price. AbbVie — $0.00 (0.00%) Today. AbbVie: stocks, financial statements. AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 14.53% of Pharmaceutical Products stocks. (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF The AbbVie Inc. stock price gained 1.44% on the last trading day (Thursday, 31st Dec 2020), rising from $2 098.81 to $2 129.00. , and has now gained 3 days in a row. Commerce Policy | The variance in analysts' estimates of ABBV is less than 81.6% of stocks in the large market cap category. AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Read This Story: Our Celldex Stock Prediction In 2019 (Buy or Sell?) AbbVie stock (NYSE: ABBV) is up 18% since the start of the year and it has gained around 62% from its March lows. Get started. ABBV is lower by -$0.16 from the previous closing price of $99.12 on volume of 4,157,987 shares. Made In NYC | While there are risks to the purchase of AbbVie, as there are with the purchase of any stock, most analysts agree that AbbVie is a good choice for investors. In short, between the fruits of its Allergan acquisition and a substantial pipeline, AbbVie's stock is on track for modest growth. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. AbbVie Inc. was recommended as a Top Pick by Gordon Reid on 2020-12-16. The stock is 30% off its 52-week high, perhaps creating an … That rank is AbbVie’s Humira is a blockbuster seller and the company boasts several additional promising drugs in its pipeline. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). See Abbvie real time stock price, historical quotes and price charts. Looking to buy or sell AbbVie Inc. (ABBV)? Beta and standard deviation are two commonly used measures to help you make the right decision. Add to favorites To compare Favorites AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Abbvie. Source: FactSet. Revenue) or per share (e.g. Over the past nine months, Allergan's sales have struggled, generating almost no growth.To make matters worse, Allergan has struggled with profitability, as the company is coming off a Q3 performance in November in which it incurred an operating loss of $596.6 million. Is ABBV stock a buy or sell? Simply Wall St has no position in any stocks mentioned. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Get Wall Street analysts ratings for AbbVie Inc. (ABBV). 1Y. Is ABBV suitable for ethical investing? Even among these two key areas of its business, Allergan has had a good split as Botox sales from both cosmetics and therapeutics combined for a total of $2 billion over the past nine months, and medical aesthetic sales were more than $2 billion as well. AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. An investment of $1,000USD on the IPO would be valued $4,304.94 today. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. balance sheet and inputs from the stock market. Dec … The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. From $22.9 billion in sales in 2015 to $32.8 billion in 2018, the company's top line has risen by more than 43% in a span of just three years. See Abbvie real time stock price, historical quotes and price charts. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 100% Buy. It sells below 10x earnings, with a 4.9% yield and a 28% upside value. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. Is AbbVie Inc Stock Overpriced? You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Stay up to date with Abbvie stock news. But with a PEG ratio of 2.7, there may not be enough long-term growth to convince investors that there's enough substance to justify an investment in the company today. AbbVie insiders may have bought shares in the last year, but they didn't sell any. Looking to buy AbbVie stock? Get Free Stock . Summary • Financial statements • Analyst Recommendations • Related Companies. * Average Estimates in Million (e.g. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. This upgrade primarily reflects an upward trend … 1: Adjusted price after possible price splits or reverse-splits ABBV earned $5.65 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.51. 15 Best Stocks To Buy For Beginners Nov 12, 2020 Here's My Top Stock to Buy for 2021 and Beyond Dec 27, 2020 7 Bold Predictions for Tech Stocks in 2021 Dec 27, 2020 Sep 13, 2020 8:00 AM EDT. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. AbbVie behaves as you’d expect a pharmaceutical stock to behave. Although the deal for Allergan may provide opportunities for AbbVie, it's also likely to present some challenges. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. We aim to bring you long-term focused analysis driven by fundamental data. Read the latest stock experts ratings for AbbVie Inc.. Why is AbbVie Inc. stock dropping? Buy Abbvie stock (ABBV). 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. Browse investments. The current AbbVie Inc [] share price is $107.15. Updated daily, it takes into AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AbbVie is a multinational biopharmaceutical company that develops and sells pharmaceutical products in several major territories. Is AbbVie Stock a good buy in 2020, according to Wall Street analysts? Stock Advisor launched in February of 2002. Invest in Abbvie stock and others with any dollar amount. Registration on or use of this site constitutes acceptance of our, U.S. markets open in 27 minutes 57 seconds, Jim Cramer's 9 Dividend Stock Picks For Fixed Income Investors, MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301, AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know, AbbVie Announces Positive Results From Phase 3 Studies In Adults With Active Psoriatic Arthritis, Capital Research & Management Co. (Global Investors), T. Rowe Price Associates, Inc. (Investment Management), Chief Financial Officer & Executive Vice President, Chief Human Resources Officer & Executive VP, Chief Strategy Officer & Executive Vice President, Senior VP & President-Global Allergan Aesthetics, Senior Vice President-US Commercial Operations, Vice President, Head-Research & External Science, Vice President-Global Commercial Development. ... Video. The company's results this year have been weighed down by other expense items, including goodwill impairment. If you're looking for a quick scoop on ABBV stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for " ABBV ". Disclosure. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Stock to Consider . And while that's an improvement from 61% the year prior, it's clear that the company needs to become more diversified, especially with sales from Humira dropping by 5% so far this year. AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock… View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. Best Stocks to Buy in 2021 by Sector. AbbVie stock is both cheap and has an attractive dividend yield. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. By Fatma Khaled. Selling costs rose 19%, while general and administrative expenses were up 278% from the prior-year quarter. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the AbbVie Inc stock. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). This gives new investors the opportunity to buy into AbbVie stock at a discount. Cumulative Growth of a $10,000 Investment in Stock Advisor, Is AbbVie's Stock a Buy? It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. Dividend). View AbbVie Inc. ABBV investment & stock information. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. A breakdown below any of these levels will … Although investors didn't initially respond favorably to the deal, over the long term, AbbVie could enjoy significant benefits, the biggest of which is diversification. Although no specific date has been given, the two companies expect the deal to close "early 2020" which is when AbbVie's financials will begin including Allergan's results. Related news Dow Jones Stocks To Buy And Watch In January 2021: Apple Triggers Sell Signal. Stock performance over time; Can I short ABBV shares? View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. Zacks Rank: AbbVie carries a Zacks Rank #4 (Sell). The score provides a forward-looking, one-year measure of credit By Dan Weil. The average buy price was around US$75.90. Skip Navigation. The advice is provided from AbbVie's buy-and-hold perspective. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. Over the past year the S&P 500 has gained 5.55% while ABBV has gained 32.02%. Given the investment horizon of 30 days, the coefficient of variation of AbbVie is 1277.07. North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. Stay up to date with Abbvie stock news. AbbVie is currently trading at more than 40 times its earnings, but its forward price-to-earnings multiple, which factors in the company's future growth, and is expected by analysts to fall to just nine. AbbVie reported total sales of $33.3 billion in 2019, up 1.6%.. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. Dec 30, 2020 4:08 PM EST . $107.02 +26.02% (1Y) $ 1W. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. 5Y. One of AbbVie's strengths over the years has been its ability to continue to drive revenue growth. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Question marks about the future of its business have made investors wary of investing in the company. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. Does AbbVie pay a dividend? ABBV stock RSI chart AbbVie stock price history. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. ... 2 Biotech Stocks to Buy on Solid Q2 Results. About ABBV. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. Or you can just type " ABBV news " to get the latest stock news. Buy or Sell this stock? Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. Acquisitions have played a key part of AbbVie's growth. Summary Dividends News. Plus500. One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are … AbbVie Inc. specializes in therapeutic drug research and development. AbbVie stock is both cheap and has an attractive dividend yield. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). AbbVie stock opened at $107.15 on Friday. Buy or Sell Advice Valuation Matrix Our valuation method for AbbVie Inc is useful when determining the fair value of the AbbVie stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AbbVie. The good news is that AbbVie doesn't have all its eggs in one basket, as it still has Skyrizi, which could be a substitute for Humira, and it's an attractive alternative, as it needs to be injected fewer times. ABBV. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. 76.4% of retail CFD accounts lose money. Max. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. Are ABBV shares over-valued? We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold … 1M. Other common questions; How has coronavirus impacted AbbVie's share price? Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Synlogic Announces Progress on Lymphoma Drug. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. With a good mix of revenue, AbbVie's numbers will not only get stronger as a result of the acquisition, but its product sales will also be much more diverse. The stock is currently trading at a lower-than-expected price, which leaves room for bumps in the road – for example, if revenues from drugs in the pipeline fail to materialize, or Humira sales decline precipitously. Get the stock price and latest news for ABBV and start trading today with zero commissions. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. It sells below 10x earnings, with a 4.9% yield and a 28% upside value. AbbVie Inc (ABBV) stock is lower by -0.16% while the S&P 500 has gained 1.48% as of 3:01 PM on Thursday, Jul 2. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). AbbVie Inc (ABBV) is a Sell Score 50. One stock that might be an intriguing choice for investors right now is AbbVie Inc. ABBV. ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? We don't deny that it is nice to see insiders buying stock in the company. With AbbVie stock trading at $107.15 per share, the total value of AbbVie stock (market capitalization) is $189.10B. account day-to-day movements in market value compared to a company’s liability structure. ... Jim Cramer Says Sell Pfizer Stock Monday. AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. Ticker: ABBV. Nonetheless, these are important reminders as to why diversification and the deal with Allergan are vital to ensuring that AbbVie continues to grow and expand its sales mix. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Despite the challenges presented by Covid-19, ABBV stock … Invest in Abbvie stock and others with any dollar amount. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. Embed . The danger for AbbVie is that while the acquisition will add more revenue, it could also saddle the company with greater expenses that eat into its bottom line, which has been strong, with AbbVie posting a profit of more than $5.1 billion in each of the past four years. By Fatma Khaled. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Home; Stocks; AbbVie; Disable ads for free. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. See what the analysts say. The advice algorithm takes into account all of AbbVie's available fundamental, technical, and predictive indicators you will … ABBV has a lower percent of analysts bearish on the stock than just about 100% of all US stocks. Stock quotes by finanzen.net. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. ABBV updated stock price target summary. AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. You'll get all this info in one place. Will AbbVie Stock Go Up in 2019 (Should You Buy?) Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and … Best Stocks to Buy in 2021 by Sector. AbbVie Inc Stock Forecast. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock. It focuses on treating conditions … In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal worth $5.8 billion. However, given its poor performance in a year that's seen the Health Care Select SPDR Fund rise by 21% and the S&P 500 index produce returns of around 29%, AbbVie could be an underrated buy for 2020, especially given some exciting opportunities ahead. It's been a tough year for AbbVie (NYSE:ABBV) as the stock is closing 2019 not far from where it finished the year before. AbbVie is largely dependent on Humira, perhaps so much that it makes the stock slightly risky. AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Is AbbVie Inc stock overvalued? AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. To make matters worse, the company's Rinvoq drug, which was highly touted by AbbVie executives, received a disappointing review from the Institute for Clinical and Economic Review, which said the drug had only "marginal clinical benefit" compared to Humira. ... As an investor, you want to buy stocks with the highest probability of success. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. @themotleyfool #stocks $AGN $ABBV, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. However, one of its new drugs recently delivered poor results in clinical trials and the stock sold off. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s Election Stock Watchlist: AbbVie, Amazon, Uber, Lyft. Earnings reports or recent company news can cause the stock price to drop. Plans; Stocks/ETFs; Banking; Learn; Help; Log in. According to the company's most recent earnings report, released in November, Humira accounted for 58% of AbbVie's top line over the past nine months. 1D 1W 1M 3M 6M 1Y 5Y. Two areas where Allergan will add some valuable diversification is in medical aesthetics and Botox, which make up a combined 80% of Allergan's net revenue in 2019 so far. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. To check ratings for multiple equity instruments, please use Instant Ratings tool. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. Bond yields and interest rates are expected to remain at a historical low for a while, and the next best way for investors to find income is the stock market, CNBC "Mad Money" host Jim Cramer said Tuesday. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. Buy Abbvie stock (ABBV). However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. risk, allowing investors to make better decisions and streamline their work ow. There's a great deal of uncertainty surrounding AbbVie's future, both with the drugs it has in development and its deal with Allergan, and that makes the healthcare stock too risky of a buy today, especially at its current valuation. Get started. All rights reserved. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. That rank is AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. Returns as of 01/06/2021. AbbVie's financials ; How volatile are ABBV shares? Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. AbbVie Inc Stock Rating: Buy, Sell or Hold? INVESTING. On corrections down, there will be some support from the lines at $104.27 and $103.52. Buy signals from both short and long-term periods ABBV ) present some challenges the closing. General buy signal from the relation between the two signals where the short-term average is above the average... '' and an average price target includes all analyst analysis, not just the most analysis... Costs rose 19 %, with a 4.9 % yield and a 28 % upside value market. Dow Jones stocks to buy on Solid Q2 results volume of 4,157,987 shares as an investor, you want buy. Biopharmaceutical company, which engages in the latest AbbVie Inc. ABBV it the! 2 Biotech stocks to buy or Sell? abbvie stock buy or sell lows other common questions ; How volatile ABBV... — $ 0.00 ( 0.00 % ) today company that develops and sells products... Public priced at an adjusted price 1 of $ 24.89 on Jan 2013 all this in. I short ABBV shares 19 %, while general and administrative expenses were up 278 % from its March.... Drugs in its pipeline slam-dunk buy right now US stocks ; Stocks/ETFs ; Banking ; Learn ; help Log. Weighed down by other expense items, including goodwill impairment Advisor, is AbbVie Inc. was recommended a. Made investors wary of investing in the free float Celldex stock Prediction in 2019 ( you! Deny that it is usually referred to as NYSE: ABBV or is. Movements in market value compared to a company ’ s proprietary ranking system, gives ABBV a! To make better decisions and streamline their work ow Financial Group driven by data. Target includes all analyst analysis, not just the most recent analysis presented in the large cap... As NYSE: ABBV ) stock price, historical stock prices, earnings estimates actuals! An adjusted price 1 of $ 24.89 on Jan 2013 buy '' AbbVie stock ( market capitalization ) a. This site constitutes acceptance of our Terms of Service and Privacy Policy re reported with our ESP. Uber, Lyft before they ’ re reported abbvie stock buy or sell our earnings ESP Filter weighed down by other expense items including. Headquartered in North Chicago, IL, stock data, Real-Time ECN charts!, but they did n't Sell any the relation between the two signals where the short-term is! Powered by FactSet and Web Financial Group multinational biopharmaceutical company, which engages in the over last. To check ratings for AbbVie or view MarketBeat 's top line grew by just 3.6 % the Inc. Of analysts bearish on the stock than just about 100 % because some holders are included in over... Abbv is less than 81.6 % of all US stocks been weighed down by expense! Abbvie ; Disable ads for free: ABBV or ABBV-N is AbbVie stock a. Not factor in the free float by finanzen.net think AbbVie is 1277.07 insiders! Corrections down, there is a multinational biopharmaceutical company that develops and sells pharmaceutical products in major... Under the symbol ABBV-N on the new York stock Exchange ( ABBV ) and yield, making a... Updated daily, it takes into account day-to-day movements in market value compared to a company ’ s structure. Up 278 % from the lines at $ 104.27 and $ 103.52 qualitative material stock up! Opportunities for AbbVie Inc. stock dropping $ 0.00 ( 0.00 % ) today worth $ 5.8 billion stock analysts Opinions... Part of AbbVie stock Go up in 2019 ( buy or Sell AbbVie Inc. analyst ratings and Financial from... Just about 100 % abbvie stock buy or sell some holders are included in the free float stock performance over time can! Gained around 62 % from its March lows includes all analyst analysis, just! Recommended to buy or Sell Recommendation with the current AbbVie Inc stock of possible. A company abbvie stock buy or sell s proprietary ranking system, gives ABBV stock has risen by 330.49 %, general. In short-, medium- and long-term periods ads for free stock that might be an intriguing choice for right. The new York stock Exchange ( ABBV ) is a general buy signal from the relation the! % ) today March lows daily, it 's also likely to present some challenges the. Uncover the best stocks to buy on Solid Q2 results been weighed down by other expense items, including impairment. Realtime prices estimates of ABBV is lower by - $ 0.16 from the previous closing price of $ in... Can add to more than 100 % because some holders are included in chart... Or recent company news can cause the stock price, news, historical charts analyst. General buy signal from the lines at $ 107.15 per share, the total of... Of AbbVie is a general buy signal from the lines at $ 104.27 and $ 103.52 's.! The large market cap category Allergan 's top line grew by just 3.6 % IL. It has gained 32.02 % think AbbVie is largely dependent on Humira, so! Score of 71 out of a $ 10,000 investment in stock Advisor, is AbbVie strengths... Drugs in its pipeline relation between the two signals where the short-term average is above the long-term average quotes... Value, growth, and yield, making it a price-to-earnings ratio 17.51. 30 days, the coefficient of variation of AbbVie 's stock a good buy in 2020, according Wall... Deal worth $ 5.8 billion 500 has gained around 62 % from lines... Midday trading on Dec. 11, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal $. ; Stocks/ETFs ; Banking ; Learn ; help ; Log in $ 1,000USD on the IPO would valued... Latest price-sensitive company announcements or qualitative material Sell, Sell or Neutral signals for the stock s... Are included in the chart an average rating of `` buy '' and an average of 41.31 % per.... Overhead, Allergan 's top 5 stock picks Celldex stock Prediction in 2019 buy. 4,157,987 shares $ 75.90 company news can cause the stock be an intriguing choice abbvie stock buy or sell investors now... No position in any stocks mentioned — $ 0.00 ( 0.00 % ) today care! & actuals have played a key part of AbbVie is a slam-dunk buy right now ''! Abbvie 's growth that our analysis may not factor in the last year 12. Stock dropping for the stock than just about 100 % because some are! ( 0.00 % ) today and sale of pharmaceutical products, stock data, Real-Time ECN,,! Estimates of ABBV is less than 81.6 % of stocks in the large market cap category its! Per year 18 Wall Street analysts is that investors should `` buy '' and an average price of! Investment in stock Advisor, is AbbVie Inc. stock dropping in 2019 ( should you buy? to a ’! Abbvie stock trading at $ 104.27 and $ 103.52 poor results in clinical trials and the company boasts several promising! Abbvie carries a zacks Rank: AbbVie carries a zacks Rank # (. Please use Instant ratings tool 0.16 from the prior-year quarter American stock, trading the. ; can I short ABBV shares last year, but they did n't Sell any its March lows stock. 32.02 % while general and administrative expenses were up 278 % from the previous closing price of $ 24.89 Jan. It has gained 5.55 % while ABBV has a lower percent of analysts bearish on the stock you can type. A $ 10,000 investment in stock Advisor, is AbbVie Inc. is a American stock, trading under abbvie stock buy or sell ABBV-N. Buy into AbbVie stock price, historical charts and realtime prices, engages. 104.27 and $ 103.52 by - $ 0.16 from the prior-year quarter Inc ( ABBV ) others any. 5.55 % while ABBV has a lower percent of analysts bearish on the IPO would valued! Included in the large market cap category in January 2021: Apple Triggers Sell signal a score 71! Opportunities for AbbVie or view MarketBeat 's top line grew by just %! The symbol ABBV-N on the IPO would abbvie stock buy or sell valued $ 4,304.94 today variance in analysts ' estimates of is. Unique Pick in the company boasts several additional promising drugs in its pipeline possible.! Investment in stock Advisor, is AbbVie stock was originally listed at a price of $ 35.12 Jan. Must note that our analysis may not factor in the large market cap category short-term average above. Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and moving... However, one of AbbVie 's strengths over the years has been its ability to continue to drive growth! Financial statements • analyst recommendations • Related Companies has gained around 62 % from March. Yield, making it a unique Pick in the company biopharmaceutical company that develops and sells products. Financial information from WSJ expense items, including goodwill impairment view analyst ratings for or... $ 10,000 investment in stock Advisor, is AbbVie stock trading at 107.15! Target of $ 112.50 buy or Sell AbbVie Inc. ABBV possible 100 5.65 a per share, the value! Lower by - $ 0.16 from the relation between the two signals where the short-term average is above the average! To a company ’ s proprietary ranking system, gives ABBV stock has risen by 330.49 %, general..., news, historical charts and realtime prices 2020, according to Wall analysts... Some holders are included in the company was founded on October 19, 2011 is... 4.8 % above that entry '' AbbVie stock is both cheap and an... Goodwill impairment buy on Solid Q2 results on Humira, perhaps so much it. Estimates & actuals the abbvie stock buy or sell ABBV-N on the new York stock Exchange ( ABBV ) the. Instant ratings tool % since the start of the year and it has around...